272 related articles for article (PubMed ID: 37406506)
41. pH-Dependent Phase Behavior and Stability of Cationic Lipid-mRNA Nanoparticles.
Larson NR; Hu G; Wei Y; Tuesca AD; Forrest ML; Middaugh CR
J Pharm Sci; 2022 Mar; 111(3):690-698. PubMed ID: 34774918
[TBL] [Abstract][Full Text] [Related]
42. Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles.
Lewis MM; Soto MR; Maier EY; Wulfe SD; Bakheet S; Obregon H; Ghosh D
Bioeng Transl Med; 2023 Nov; 8(6):e10580. PubMed ID: 38023707
[TBL] [Abstract][Full Text] [Related]
43. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm.
Wang W; Feng S; Ye Z; Gao H; Lin J; Ouyang D
Acta Pharm Sin B; 2022 Jun; 12(6):2950-2962. PubMed ID: 35755271
[TBL] [Abstract][Full Text] [Related]
44. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
[TBL] [Abstract][Full Text] [Related]
45. Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA.
Blakney AK; McKay PF; Yus BI; Aldon Y; Shattock RJ
Gene Ther; 2019 Sep; 26(9):363-372. PubMed ID: 31300730
[TBL] [Abstract][Full Text] [Related]
46. An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses.
Oyama R; Ishigame H; Tanaka H; Tateshita N; Itazawa M; Imai R; Nishiumi N; Kishikawa JI; Kato T; Anindita J; Nishikawa Y; Maeki M; Tokeshi M; Tange K; Nakai Y; Sakurai Y; Okada T; Akita H
ACS Nano; 2023 Oct; 17(19):18758-18774. PubMed ID: 37814788
[TBL] [Abstract][Full Text] [Related]
47. Minimizing the ratio of ionizable lipid in lipid nanoparticles for
Chen Q; Wang X; Zhang Y; Tian M; Duan J; Zhang Y; Yin H
Natl Sci Rev; 2024 Jun; 11(6):nwae135. PubMed ID: 38770531
[TBL] [Abstract][Full Text] [Related]
48. Data-balanced transformer for accelerated ionizable lipid nanoparticles screening in mRNA delivery.
Wu K; Yang X; Wang Z; Li N; Zhang J; Liu L
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38670158
[TBL] [Abstract][Full Text] [Related]
49. Induction of Bleb Structures in Lipid Nanoparticle Formulations of mRNA Leads to Improved Transfection Potency.
Cheng MHY; Leung J; Zhang Y; Strong C; Basha G; Momeni A; Chen Y; Jan E; Abdolahzadeh A; Wang X; Kulkarni JA; Witzigmann D; Cullis PR
Adv Mater; 2023 Aug; 35(31):e2303370. PubMed ID: 37172950
[TBL] [Abstract][Full Text] [Related]
50. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
Qiu M; Li Y; Bloomer H; Xu Q
Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
[TBL] [Abstract][Full Text] [Related]
51. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
[TBL] [Abstract][Full Text] [Related]
52. Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment.
Zhang M; Jiang H; Wu L; Lu H; Bera H; Zhao X; Guo X; Liu X; Cun D; Yang M
J Control Release; 2022 Dec; 352():422-437. PubMed ID: 36265740
[TBL] [Abstract][Full Text] [Related]
53. Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing.
El-Mayta R; Padilla MS; Billingsley MM; Han X; Mitchell MJ
J Vis Exp; 2023 Jan; (191):. PubMed ID: 36744791
[TBL] [Abstract][Full Text] [Related]
54. Modulating the Nature of Ionizable Lipids and Number of Layers in Hyaluronan-Decorated Lipid Nanoparticles for In Vitro Delivery of RNAi.
Passos Gibson V; Tahiri H; Gilbert C; Yang C; Phan QT; Banquy X; Hardy P
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675224
[TBL] [Abstract][Full Text] [Related]
55. Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion.
Aliakbarinodehi N; Gallud A; Mapar M; Wesén E; Heydari S; Jing Y; Emilsson G; Liu K; Sabirsh A; Zhdanov VP; Lindfors L; Esbjörner EK; Höök F
ACS Nano; 2022 Dec; 16(12):20163-20173. PubMed ID: 36511601
[TBL] [Abstract][Full Text] [Related]
56. Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen.
Kimura S; Khalil IA; Elewa YHA; Harashima H
J Control Release; 2021 Feb; 330():753-764. PubMed ID: 33422500
[TBL] [Abstract][Full Text] [Related]
57. β-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model.
Nelson AL; Mancino C; Gao X; Choe JA; Chubb L; Williams K; Czachor M; Marcucio R; Taraballi F; Cooke JP; Huard J; Bahney C; Ehrhart N
Bioact Mater; 2024 Sep; 39():273-286. PubMed ID: 38832305
[TBL] [Abstract][Full Text] [Related]
58. Structure of Lipid Nanoparticles Containing siRNA or mRNA by Dynamic Nuclear Polarization-Enhanced NMR Spectroscopy.
Viger-Gravel J; Schantz A; Pinon AC; Rossini AJ; Schantz S; Emsley L
J Phys Chem B; 2018 Feb; 122(7):2073-2081. PubMed ID: 29332384
[TBL] [Abstract][Full Text] [Related]
59. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
[TBL] [Abstract][Full Text] [Related]
60. One-Component Cationic Lipids for Systemic mRNA Delivery to Splenic T Cells.
Zhang X; Su K; Wu S; Lin L; He S; Yan X; Shi L; Liu S
Angew Chem Int Ed Engl; 2024 Jun; 63(26):e202405444. PubMed ID: 38637320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
